GI
Grifols, S.A.
GIKLY · OTC
$5.78 +0.52% (+$0.03)
1M -0.52%
Market Cap 13.1B €
P/E Ratio 28.87x
Div. Yield 0.82%
ROE 8.43%
Bulios Fair Price
$3.92
32.2% downside
Trenutna cena
$5.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GIKLY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
66 /100
Fair P/E 28.87x
EV/EBITDA 13.01x
PEG 0.23x
Growth
64 /100
Stable EPS growth 20.51%
Rev. growth 7.46%
Book val. growth 4.92%
Profitability
64 /100
Moderate Gross margin 37.23%
Net margin 6.09%
FCF margin 10.19%
Quality
31 /100
Poor ROIC 5.48%
ROE 8.43%
Asset turnover 0.37x
Debt
35 /100
Moderate Debt/Equity 1.54x
Current ratio 2.37x
Net debt/EBITDA 4.94x
Stability
61 /100
Moderate Beta 1.19x
Rev. volatility 2.76%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GIKLY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jose Ignacio Abia Buenache
Employees
25,258
Headquarters
Barcelona
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report